Transparency Market Research Radiopharmaceuticals Market is growing at a CAGR of 18.3% from 2013 to 2019. By Transparency Market Research.
Single User License:
USD 4595 Multi User License:
USD 7595 Corporate User License:
USD 10595
Published Date 20-Feb-2013
127 Page Report
Request Sample
Buy Now
Press Release
Radiopharmaceuticals Market is growing at a CAGR of 18.3% from 2013 to 2019. By Transparency Market Research. Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Radiopharmaceuticals Market
REPORT DESCRIPTION
Radiopharmaceuticals Market was valued at approximately USD 3.8 billion in 2013 and is expected to reach USD 12.2 billion by 2019 at a CAGR of 18.3% from 2013 to 2019. North America led the global radiopharmaceuticals market with the highest market share as Canada continues to be the largest exporter of uranium and nuclear technology, forming the backbone of nuclear medicine and imaging studies.
Browse the full report at http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html
The market is expected to grow at a CAGR of 18.3% owing to tremendous research and technological developments occurring worldwide and the increasing awareness about nuclear medicine and molecular imaging procedures. The radiopharmaceuticals market is studied based on end-user groups, medical isotopes, applications and geography. Technetium (Tc-99m) is the most widely used radioisotope for medical applications. The majority of the application market for radiopharmaceuticals is constituted by the diagnosis market, and the therapeutic application segment is expected to grow at the fastest growth rate from 2012 to 2018. The global market for generators for radiopharmaceuticals was valued at over USD 200 million in 2011 and is expected to grow at a healthy CAGR from 2012 to 2018. The market currently consists only of Tc-99m generators; newer generators for molecules like Rubidium (Rb-82), Gallium (Ga-67) and Yttrium (Y-90) are expected to enter the market in the next few years. These are expected to exhibit high double digit growth rates during the forecast period.
Key players in this market include Covidien Plc, Nordion Inc., Lantheus Medical Imaging and IBA Group, among others. The market is highly fragmented with leading global healthcare companies offering a wide range of diagnostic and therapeutic radiopharmaceuticals. The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the radiopharmaceuticals market as below:
Transparency Market Research
2
Radiopharmaceuticals Market
Radiopharmaceuticals Market by Generator Types Mo-99/Tc-99m generator Sr-82/Rb-82 generator Ge-68/Ga-68 generator Sr-90/Y-90 generator W-188/Re-188 generator Radiopharmaceuticals Market by End-Users Hospitals & Medical Centers Diagnostic Centers Radiopharmaceuticals Market by Applications Diagnosis Diagnosis by Technique SPECT Technetium (Tc-99m) Thallium (TI-201) Gallium (Ga-67) Iodine (I-123) Rhenium (Re-186) Yttrium (Y-90) Others PET
Transparency Market Research
3
Radiopharmaceuticals Market Fludeoxyglucose (18F-FDG) Rubidium (Rb-82) Others (Carbon-11 choline, Nitrogen-13 ammonia) Diagnosis by Indications Oncology Cardiovascular Others (Neurological, Thyroid, Gastrointestinal) Therapy Systemic Oncology Iodine (I-131) Yttrium (90Y) Samarium (Sm-153) Strontium (89Sr) Rhenium (186Re) Lutetium (Lu-177) Erbium (169Er) Others Others (Cardiology, Neurology) Radiopharmaceuticals Market by Geography North America Europe Asia-Pacific
Transparency Market Research
4
Radiopharmaceuticals Market Rest of the World (RoW)
For Sample Report Visit On: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213
TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Global Radiopharmaceuticals Market Overview 3.1 Overview 3.2 Market Drivers 3.2.1 Radiopharmaceutical-Based Cancer Therapy 3.2.2 Growing Preference For Disease-Targeted Therapy 3.2.3 Increasing Awareness Of Accurate Diagnosis
Transparency Market Research
5
Radiopharmaceuticals Market 3.2.4 Expanding Molecular Imaging Applications 3.3 Market Restraints 3.3.1 Strict Regulatory Guidelines For Production, Storage and Usage 3.3.2 Worldwide Supply Shortages 3.3.3 Price Sensitivity And Competitive Alternatives 3.4 Market Opportunities 3.4.1 Increasing Demand For Accurate Diagnosis and Treatment, Particularly In Emerging Markets 3.4.2 Radiopharmaceutical-Based Personalized Therapy
Chapter 4 Market Definition & Supply Chain Analysis 4.1 Market Definition 4.2 Radiopharmaceutical Production : A Global Perspective 4.3 Supply Chain Analysis
Chapter 5 Global Radiopharmaceutical Generators Market 5.1 Overview 5.1.1 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USD Million) 5.2 Mo-99/Tc-99m Generators 5.3 Sr-82/Rb-82 Generators 5.4 Ge-68/Ga-67,68 Generators
Transparency Market Research
6
Radiopharmaceuticals Market 5.5 Sr-90/Y-90 Generators 5.6 W-188/Re-188 Generators
Chapter 6 Global Radiopharmaceuticals Market, By End-User Groups 6.1 Overview 6.1.1 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USD Million) 6.2 Hospitals and Medical Centers 6.2.1 Global Radiopharmaceuticals Market By End User Groups : Hospitals and Medical Centres, 2010 – 2018 (USD Million) 6.3 Outpatient Diagnostic Centers 6.3.1 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres, 2010 – 2018 (USD Million)
Chapter 7 Global Radiopharmaceuticals Market, By Applications 7.1 Overview 7.2 Radiopharmaceuticals For Diagnosis 7.2.1 Overview 7.2.2 Radiopharmaceuticals For Diagnosis, By Technique 7.2.2.1 Single-Photon Emission Computed Tomography (SPECT) 7.2.2.1.1 Comparative Analysis: SPECT Radioisotopes Market, 2011 & 2018 (%)
Transparency Market Research
7
Radiopharmaceuticals Market 7.2.2.1.2 Technetium (Tc-99m) 7.2.2.1.3 Thallium (Tl-201) 7.2.2.1.4 Gallium (Ga-67) 7.2.2.1.5 Iodine (I-123) 7.2.2.1.6 Rhenium (Re-186) 7.2.2.1.7 Yttrium (Y-90) 7.2.2.1.8 Others 7.2.2.2 Positron Emission Tomography (PET) 7.2.2.2.1 Comparative Analysis: PET Radioisotopes Market, 2011 & 2018 (%) 7.2.2.2.2 Fludeoxyglucose (18f-FDG) 7.2.2.2.3 Rubidium (Rb-82) 7.2.2.2.4 Others (Carbon-11 Choline, Nitrogen13 Ammonia) 7.2.3 Radiopharmaceuticals For Diagnosis, By Indications 7.2.3.1 Oncology 7.2.3.2 Cardiovascular 7.2.3.3 Others (Neurological, Thyroid, Gastrointestinal) 7.3 Radiopharmaceuticals For Therapy 7.3.1 Overview 7.3.2 Oncology (Systemic Therapy) 7.3.2.1 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 & 2018 (%)
Transparency Market Research
8
Radiopharmaceuticals Market 7.3.2.2 Iodine (I-131) 7.3.2.3 Yttrium (Y-90) 7.3.2.4 Samarium (Sm-153) 7.3.2.5 Strontium (Sr-89) 7.3.2.6 Rhenium (186Re) 7.3.2.7 Lutetium-177 (Lu-177) 7.3.2.8 Erbium-169 (169Er) 7.3.2.9 Others 7.3.3 Other Applications In Therapy (Cardiology, Neurology) 7.4 Theranostics
Chapter 8 Global Radiopharmaceuticals Market, By Geography 8.1 Overview 8.2 North America 8.2.1 North America Radiopharmaceuticals Market - Diagnosis and Systemic Therapy, 20102018 (USD Million) 8.2.2 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million) 8.3 Europe 8.3.1 Europe Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million) 8.3.2 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Transparency Market Research
9
Radiopharmaceuticals Market 8.4 Asia-Pacific (Apac) 8.4.1 Asia-Pacific Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 20102018 (USD Million) 8.4.2 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million) 8.5 Rest of the World (RoW) 8.5.1 RoW Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million) 8.5.2 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Chapter 9 Market Share Analysis By Key Players 9.1 Radiopharmaceuticals Market 9.2 Generators Market
Chapter 10 Recommendations 10.1 Identification and Elimination Of Barriers 10.2 Development of Total Solutions 10.3 Investing in Emerging Markets 10.4 Entering Monopoly Markets
Chapter 11 Company Profiles 11.1 Cardinal Health Inc.
Transparency Market Research
10
Radiopharmaceuticals Market 11.1.1 Company Overview 11.1.2 Financial Overview 11.1.3 Business Strategies 11.1.3.1 Mergers and Acquisitions 11.1.3.2 External Funding 11.1.3.3 Incorporation of Advanced Technologies to Support Business Development 11.1.4 Product Portfolio 11.1.5 Recent Developments 11.2 Covidien Plc 11.2.1 Company Overview 11.2.2 Product Portfolio 11.2.3 Financial Overview 11.2.4 Strategic Overview 11.2.4.1 Mergers and Acquisitions 11.2.4.2 Approvals 11.2.5 Recent Developments 11.3 GE Healthcare 11.3.1 Company Overview 11.3.2 Product Portfolio 11.3.3 Financial Overview
Transparency Market Research
11
Radiopharmaceuticals Market 11.3.4 Strategic Overview 11.3.4.1 Mergers and Acquisitions 11.3.5 Recent Developments 11.4 IBA Group 11.4.1 Company Overview 11.4.2 Financial Overview 11.4.3 Product Portfolio 11.5 Lantheus Medical Imaging 11.5.1 Company Overview 11.5.2 Financial Overview 11.5.3 Business Strategies 11.5.3.1 Rigorous Research and Development Initiatives 11.5.3.2 Selling Generic Products to Maintain Market Share 11.5.4 Product Portfolio 11.5.4.1 Recent Developments 11.6 Monrol Nuclear Products, Inc. 11.6.1 Company Overview 11.6.2 Product Portfolio 11.6.3 Strategic Overview 11.6.3.1 Mergers and Acquisitions
Transparency Market Research
12
Radiopharmaceuticals Market 11.6.3.2 Collaborations 11.6.4 Recent Developments 11.7 Nordion, Inc. 11.7.1 Company Overview 11.7.2 Product Portfolio 11.7.3 Financial Overview 11.7.4 Strategic Overview 11.7.4.1 Contracts and Agreements 11.7.4.2 Divestiture 11.7.5 Recent Developments 11.7.5.1 New Product Launch 11.8 NTP Radioisotopes (Pty) Ltd 11.8.1 Company Overview 11.8.2 Financial Overview 11.8.3 Business Strategies 11.8.3.1 Media Campaigns as a Brand Management Tool 11.8.3.2 Business Expansion through Partnerships, Collaborations and Alliances 11.8.4 Product Portfolio 11.8.5 Recent Developments 11.9 Polatom
Transparency Market Research
13
Radiopharmaceuticals Market 11.9.1 Company Overview 11.9.2 Financial Overview 11.9.3 Business Strategies 11.9.3.1 Maintaining an Extensive Network of Distributors 11.9.4 Product Portfolio 11.9.5 Recent Developments 11.10 Positron Corporation 11.10.1 Company Overview 11.10.2 Product Portfolio 11.10.3 Financial Overview 11.10.4 Strategic Overview 11.10.4.1 Contracts and Agreements 11.10.4.2 Collaborations 11.10.5 Recent Developments 11.10.5.1 Grants and Licenses 11.10.5.2 Incentives 11.11 Siemens Healthcare 11.11.1 Company Overview 11.11.2 Financial Overview 11.11.3 Business Strategies
Transparency Market Research
14
Radiopharmaceuticals Market 11.11.3.1 Investing In Emerging Economies 11.11.3.2 Rigorous Research and Development Initiatives 11.11.3.3 Identifying Key Growth Areas and Determining Short Term Goals (Agenda 2013) 11.11.3.4 Maintaining An Extensive Suppliers Network 11.11.4 Product Portfolio 11.11.5 Recent Developments
About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
15